About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Retirement of Non-Executive Director
May 19, 2016
Click here to read more
Post navigation
Previous Post
Phosphagenics Expands License Agreement for Diclofenac Gel
Next Post
2016 May 19 AGM Chairman and CEO Addresses
Related Posts
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
January 31, 2017
Dosing commences for Phase I human clinical trial
October 4, 2021
October 4, 2021
Phosphagenics Announces Equity Raising
September 26, 2017